When Clinical Development Turns into Clinical Practice
Who is it for?
Senior managers in pre-clinical and clinical development, clinical supplies units and regulatory affairs.
What business issues will we address?
Today, clinical development is too much focused on a financially risky "the-one-drug-that-cures-as-many-people-as-possible" approach. Instead, a "smaller-but-targeted" approach allows for a step-by-step development and launch with more manageable costs. In this workshop we look at the different business models of pre-clinical and clinical development in order to increase speed-to-market, minimize risks and costs and to ensure profitable results.
What will I be able to do after participating?
You will be better able to:
- Compare the strengths, weaknesses, opportunities and threats of current and new business models in pre-clinical and clinical development
- Determine the criteria for selecting the right business model for your development organization and the critical success factors for making it work
- Develop a business case for implementing a new business model
- Successfully organize and manage pre-clinical and clinical development, balancing speed, costs, risks and profits
